Hereditary prion protein amyloidoses

Clinics in Laboratory Medicine

Volumn 23, Issue 1, 2003, Pages 65-85

  Ghetti, Bernardino ^a   Tagliavini, Fabrizio ^b   Takao, M ^a   Bugiani, Orso ^b   Piccardo, Pedro ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PRION PROTEIN;

AMYLOIDOSIS; BRAIN SPONGIOSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; GENETIC DISORDER; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; VASCULAR AMYLOIDOSIS;

EID: 1642518575     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(02)00064-1     Document Type: Review

References (63)

1. Ghetti B, Piccardo P, Frangione B, et al. Prion protein amyloidosis. Brain Pathol 1996;6:127-45.
2. Ghetti B, Piccardo P, Frangione B, et al. Prion protein hereditary amyloidosis: parenchymal and vascular. Semin Virol 1996;7:189-200.
3. Gambetti P, Petersen RB, Parchi P, et al. Inherited prion diseases. In: Prusiner SB, editor. Prion biology and diseases. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1999. p. 509-83.
4. Ghetti B, Gambetti P. Human prion diseases. In: Mattson MP, editors. Advances in cell aging and gerontology, vol. 3: genetic aberrancies and neurodegenerative disorders. Greenwich (CT): Jai Press Inc.; 1999. p. 135-87.
5. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001;24:519-50.
6. Prusiner SB. An introduction to prion biology and diseases. In: Prusiner SB, editor. Prion biology and diseases. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1999. p. 1-67.
7. Ghetti B, Piccardo P, Spillantini MG, et al. Vascular variant of prion protein cerebral amyloidosis with τ-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci USA 1996;93:744-8.
8. Ghetti B, Bugiani O, Tagliavini F, et al. Gerstmann-Sträussler-Scheinker disease. Neurodegeneration. In: The molecular pathology of dementia and movement disorders, in press.
9. Furukawa H, Kitamoto T, Tanaka Y, et al. New variant prion protein in a Japanese family with Gerstmann-Sträussler syndrome. Mol Brain Res 1995;30:385-8.
10. Dimitz L. Bericht des vereines für psychiatrie und neurologie in wien. (Vereinsjahr 1912/13). Sitzung vom 11. Juni 1912. Jahrbuch Psychiatric Neurology 1913;34:384.
11. Gerstmann J. Über ein noch nicht beschriebenes reflexphanomen bei einer erkrankung des zerebellaren systems. Wien Med Wochenschr 1928;78:906-8.
12. Gerstmann J, Sträussler E, Scheinker I. Über eine eigenartige hereditär-familiäre erkrankung des zentralnervensystems. Zugleich ein beitrag zur frage des vorzeitigen lokalen alterns. Zeitschrift fur Neurologie und Psychiatrie 1936;154:736-62.
13. von Braunmühl A. Über eine eigenartige hereditär-familiäre erkrankung des zentralnervensystems. Archiv Für Psychiatrie und Zeitschrift Neurologie 1954;191:419-49.
14. Seitelberger F. Eigenartige familiär-hereditäre krankheit des zentralennervensystems in einer niederösterreichischen sippe. Wien Klin Wochenschr 1962;74:687-91.
15. Seitelberger F. Sträussler's disease. Acta Neuropathol (Berl) 1981;7:341-3.
16. Kretzschmar HA, Honold G, Seitelberger F, et al. Prion protein mutation in family first reported by Gerstmann, Sträussler, and Scheinker. Lancet 1991;337:1160.
17. Hainfellner JA, Brantner-Inthaler S, Cervenáková L, et al. The original Gerstmann-Sträussler-Scheinker (GSS) family of Austria: divergent clinicopathological phenotypes but constant PrP genotype. Brain Pathol 1995;5:201-11.
18. Ghetti B, Tagliavini F, Masters CL, et al. Gerstmann-Sträussler-Scheinker disease: II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 1989;39:1453-61.
19. Masters CL, Gajdusek DC, Gibbs CJ Jr. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaques deposition in the virus induced spongiform encephalopathies. Brain 1991;104:559-88.
20. Ghetti B, Farlow M, Conneally M, et al. Amyloid plaques and neurofibrillary tangles of Gerstmann-Sträussler-Scheinker disease. Neurology 1988;38(Suppl 1):266.
21. Farlow MR, Yee RD, Dlouhy SR, et al. Gerstmann-Sträussler-Scheinker disease: I. Extending the clinical spectrum. Neurology 1989;39:1446-52.
22. Ghetti B, Dlouhy SR, Giaccone G, et al. Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol 1995;5:61-75.
23. Ghetti B, Tagliavini F, Giaccone G, et al. Familial Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 1994;8:41-8.
24. Bugiani O, Giaccone G, Verga L, et al. βPP participates in PrP-amyloid plaques of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 1993;52:64-70.
25. Tagliavini F, Giaccone G, Prelli F, et al. A68 is a component of paired helical filaments of Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Brain Res 1993;616:325-8.
26. Giaccone G, Verga L, Bugiani O, et al. Prion protein preamyloid and amyloid deposits in the brains of patients with Gerstmann-Sträussler-Scheinker disease, Indiana kindred. Proc Natl Acad Sci USA 1992;89:9349-53.
27. Piccardo P, Seiler C, Dlouhy SR, et al. Protease-K-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease (Indiana kindred). J Neuropathol Exp Neurol 1996;55:1157-63.
28. Piccardo P, Dlouhy SR, Lievens PMJ, et al. Phenotypic variability of Gerstmann-Sträussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998;57:979-88.
29. Parchi P, Chen SG, Brown P, et al. Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci USA 1998;95:8322-7.
30. Piccardo P, Liepnieks JJ, William A, et al. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol 2001;158:2201-7.
31. Hedge RS, Mastrianni JA, Scott MR, et al. A transmembrane form of prion protein in neurodegenerative disease. Science 1998;279:827-34.
32. Chen SG, Teplow DB, Parchi P, et al. Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 1995;270:19173-80.
33. Stöckel J, Safar J, Wallace AC, et al. Prion protein selectively binds copper(II) ions. Biochemistry 1998;37:7185-93.
34. Hornshaw MP, McDermott JR, Candy JM, et al. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 1995;214:993-9.
35. Miura T, Hori-i A, Takeuchi H. Metal-dependent alpha-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett 1996;396:248-52.
36. Zhang H, Kaneko K, Nguyen JT, et al. Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J Mol Biol 1995;250:514-26.
37. Zhang H, Stöckel J, Mehlhorn I, et al. Physical studies of conformational plasticity in a recombinant prion protein. Biochemistry 1997;6:3543-53.
38. Tagliavini F, Prelli F, Porro M, et al. Amyloid fibrils in Gerstmann-Sträussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 1994;79:695-703.
39. Tagliavini F, Lievens PM, Tranchant C, et al. A 7-kDa prion protein (PrP) fragment, an integral component of the PrP region required for infectivity, is the major amyloid protein in Gerstmann-Sträussler-Scheinker disease A117V. J Biol Chem 2001;276:6009-15.
40. Tagliavini F, Prelli F, Ghiso J, et al. Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11-kD fragment of prion protein with an N-terminal glycine at codon 58. EMBO J 1991;10:513-9.
41. Gabizon R, Telling G, Meiner Z, et al. Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med 1996;2:59-64.
42. Chen SG, Parchi P, Brown P, et al. Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med 1997;3:1009-15.
43. Silvestrini MC, Cardone F, Maras B, et al. Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients. Nat Med 1997;3:521-5.
44. James TL, Liu H, Ulyanov NB, et al. Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci USA 1997;94:10086-91.
45. Riek R, Hornemann S, Wider G, et al. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 1997;413:282-88.
46. Tagliavini F, Prelli F, Verga L, et al. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc Natl Acad Sci USA 1993;90:9678-82.
47. Piccardo P, Ghetti B, Dickson DW, et al. Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. J Neuropathol Exp Neurol 1995;54:790-801.
48. Young K, Clark HB, Piccardo P, et al. Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Mol Brain Res 1997;44:147-50.
49. Kitamoto T, Amano N, Terao Y, et al. A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Ann Neurol 1993;34:808-13.
50. Yamada M, Itoh Y, Inaba A, et al. An inherited prion disease with a PrP P105L mutation: clinicopathologic and PrP heterogeneity. Neurology 1999;53:181-8.
51. Mallucci GR, Campbell TA, Dickinson A, et al. Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene. Brain 1999;122:1823-37.
52. Nochlin D, Sumi SM, Bird TD, et al. Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology 1989;39:910-8.
53. Tranchant C, Doh-ura K, Warter JM, et al. Gerstmann-Sträussler-Scheinker disease in an Alsatian family: clinical and genetic studies. J Neurol Neurosurg Psychiatry 1992;55:185-7.
54. Panegyres PK, Toufexis K, Kakulas BA, et al. A new mutation (G131V) linked to Gerstmann-Sträussler-Scheinker disease. Arch Neurol 2001;58:1899-902.
55. Butefisch CM, Gambetti P, Cervenakova L, et al. Inherited prion encephalopathy associated with the novel PRNP H187R mutation: a clinical study. Neurology 2000;55:517-22.
56. Liberski PP, Barcikowska M, Cervenakova L, et al. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol (Berl) 1998;96:425-30.
57. Liberski PP, Bratosiewicz J, Barcikowska M, et al. A case of sporadic Creutzfeldt-Jakob disease with a Gerstmann-Sträussler-Scheinker phenotype but no alterations in the PRNP gene. Acta Neuropathol (Berl) 2000;100:233-4.
58. Kitamoto T, Iizuka R, Tateishi J. An amber mutation of prion protein in Gerstmann-Straussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 1993;192:525-31.
59. Baker HF, Duchen LW, Jacobs JM, Riley RM. Spongiform encephalopathy transmitted experimentally from Cretzfeldt-Jakob and familial Gerstmann-Sträussler-Scheinker diseases. Brain 1990;113:891-1909.
60. Manuelidis EE, Fitch WW, Kim JH, Manuelidis L. Immortality of cell cultures derieved from brains of mice and hamsters infected with Cretzfeldt-Jakob disease agent. Proc Natl Acad Sci USA 1987;84:871-5.
61. Tateishi J, Kitamoto T, Hogue MZ, Furukawa H. Experimental transmission of Cretzfeldt-Jakob and related diseases to rodents. Neurology 1996;46:532-7.
62. Brown P. The phenotypic expression of different mutations in transmissible human spongiform encephalopathy. Rev Neurol (Paris) 1992;148:317-27.
63. Hsiao K, Dlouhy SR, Farlow MR, et al. Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nature Genetics 1992;1:68-71.